Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Colorectal Neoplasms

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 31 articles:
HTML format



Single Articles


    November 2022
  1. MURPHY N, Newton CC, Song M, Papadimitriou N, et al
    Body Mass Index and Molecular Subtypes of Colorectal Cancer.
    J Natl Cancer Inst. 2022 Nov 29:djac215. doi: 10.1093.
    PubMed     Abstract available


  2. COLDITZ GA
    Combined individual participant data: highest level evidence on obesity and colorectal cancer molecular subtypes.
    J Natl Cancer Inst. 2022 Nov 29:djac216. doi: 10.1093.
    PubMed    


  3. GALLICCHIO L, Devasia TP, Tonorezos E, Mollica MA, et al
    Estimation of the Number of Individuals Living With Metastatic Cancer in the United States.
    J Natl Cancer Inst. 2022;114:1476-1483.
    PubMed     Abstract available


    October 2022
  4. SHIH YT, Xu Y, Bradley C, Giordano SH, et al
    Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured.
    J Natl Cancer Inst. 2022;114:1392-1399.
    PubMed     Abstract available


    September 2022
  5. YU H, Wang X, Bai L, Tang G, et al
    DNA Methylation Profile in CpG-depleted Regions Uncovers a High-Risk Subtype of Early-stage Colorectal Cancer.
    J Natl Cancer Inst. 2022 Sep 28. pii: 6726193. doi: 10.1093.
    PubMed     Abstract available


  6. ZHANG ER, Pfeiffer RM, Austin A, Clarke MA, et al
    Impact of HIV on Anal Squamous Cell Carcinoma Rates in the United States, 2001-2015.
    J Natl Cancer Inst. 2022;114:1246-1252.
    PubMed     Abstract available


    June 2022
  7. CASTILHO JL, Bian A, Jenkins CA, Shepherd BE, et al
    CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.
    J Natl Cancer Inst. 2022;114:854-862.
    PubMed     Abstract available


  8. MOSS JL, Pinto CN, Srinivasan S, Cronin KA, et al
    Enduring Cancer Disparities by Persistent Poverty, Rurality, and Race: 1990-1992 to 2014-2018.
    J Natl Cancer Inst. 2022;114:829-836.
    PubMed     Abstract available


  9. GOLDBERG RM, Adams R, Buyse M, Eng C, et al
    Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.
    J Natl Cancer Inst. 2022;114:819-828.
    PubMed     Abstract available


    May 2022

  10. Correction to: Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests.
    J Natl Cancer Inst. 2022 May 20. pii: 6590000. doi: 10.1093.
    PubMed    


  11. CASTANON A, Parmar D, Massat N, Sasieni P, et al
    Benefit of biennial faecal occult blood screening on colorectal cancer in England: A population-based case-control study.
    J Natl Cancer Inst. 2022 May 16. pii: 6586300. doi: 10.1093.
    PubMed     Abstract available


  12. TIAN Y, Kim AE, Bien SA, Lin Y, et al
    Genome-Wide Interaction Analysis of Genetic Variants with Menopausal Hormone Therapy for Colorectal Cancer Risk.
    J Natl Cancer Inst. 2022 May 5. pii: 6581085. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  13. LADABAUM U, Church TR, Feng Z, Ransohoff DF, et al
    Counting Advanced Pre-Cancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity.
    J Natl Cancer Inst. 2022 Feb 4. pii: 6522121. doi: 10.1093.
    PubMed     Abstract available


  14. HEIN DM, Deng W, Bleile M, Kazmi SA, et al
    Racial and Ethnic Differences in Genomic Profiling of Early-Onset Colorectal Cancer.
    J Natl Cancer Inst. 2022 Feb 2. pii: 6520467. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  15. LEE LH, Davis L, Ylagan L, Omilian AR, et al
    Identification of a Subset of Stage I Colorectal Cancer Patients with High Recurrence Risk.
    J Natl Cancer Inst. 2022 Jan 30. pii: 6517508. doi: 10.1093.
    PubMed     Abstract available


  16. MURPHY N, Song M, Papadimitriou N, Carreras-Torres R, et al
    Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis.
    J Natl Cancer Inst. 2022 Jan 20. pii: 6512063. doi: 10.1093.
    PubMed     Abstract available


  17. ARCHAMBAULT AN, Jeon J, Lin Y, Thomas M, et al
    Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study.
    J Natl Cancer Inst. 2022 Jan 13. pii: 6506525. doi: 10.1093.
    PubMed     Abstract available


  18. SHANKARAN V, Unger JM, Darke AK, Suga JM, et al
    S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients.
    J Natl Cancer Inst. 2022 Jan 4. pii: 6492636. doi: 10.1093.
    PubMed     Abstract available


  19. GIOVANNUCCI E
    Molecular Biologic and Epidemiologic Insights for Preventability of Colorectal Cancer.
    J Natl Cancer Inst. 2022 Jan 3. pii: 6493343. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  20. WERNLY S, Datz C, Wernly B
    RE: Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles.
    J Natl Cancer Inst. 2021 Dec 25. pii: 6483088. doi: 10.1093.
    PubMed    


    November 2021
  21. JIN Z, Dixon JG, Fiskum JM, Parekh HD, et al
    Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database.
    J Natl Cancer Inst. 2021;113:1693-1704.
    PubMed     Abstract available


  22. CERCEK A, Chatila WK, Yaeger R, Walch H, et al
    A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.
    J Natl Cancer Inst. 2021;113:1683-1692.
    PubMed     Abstract available


  23. ENG C, Hochster H
    Early-Onset Colorectal Cancer: The Mystery Remains.
    J Natl Cancer Inst. 2021;113:1608-1610.
    PubMed    


  24. YIN J, Cohen R, Jin Z, Liu H, et al
    Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
    J Natl Cancer Inst. 2021;113:1705-1713.
    PubMed     Abstract available


  25. JOSHI AD, Chan AT
    Racial Differences in Epigenetic Aging of the Colon: Implications for Colorectal Cancer.
    J Natl Cancer Inst. 2021;113:1618-1619.
    PubMed    


  26. DEVALL M, Sun X, Yuan F, Cooper GS, et al
    Racial Disparities in Epigenetic Aging of the Right vs Left Colon.
    J Natl Cancer Inst. 2021;113:1779-1782.
    PubMed     Abstract available


    October 2021
  27. LIPSYC-SHARF M, Zhang S, Ou FS, Ma C, et al
    Survival in Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405.
    J Natl Cancer Inst. 2021 Oct 12. pii: 6390822. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  28. POST CCB, Stelloo E, Smit VTHBM, Ruano D, et al
    Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer.
    J Natl Cancer Inst. 2021;113:1212-1220.
    PubMed     Abstract available


    August 2021
  29. BREUER E, Hebeisen M, Schneider MA, Roth L, et al
    Site of Recurrence and Survival After Surgery for Colorectal Peritoneal Metastasis.
    J Natl Cancer Inst. 2021;113:1027-1035.
    PubMed     Abstract available


    April 2021
  30. WAGNER AD, Grothey A, Andre T, Dixon JG, et al
    Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.
    J Natl Cancer Inst. 2021;113:400-407.
    PubMed     Abstract available


  31. ZAANAN A, Henriques J, Cohen R, Sefrioui D, et al
    Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial Origin.
    J Natl Cancer Inst. 2021;113:496-500.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: